Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. NEUGUT AI; ROSENBERG DJ; AHSAN H; JACOBSON JS; WAHID N; HAGAN M; RAHMAN MI; KHAN ZR; CHEN L; PABLOSMENDEZ A; SHEA S
   ASSOCIATION BETWEEN CORONARY HEART-DISEASE AND CANCERS OF THE BREAST,PROSTATE, AND COLON
   Cancer epidemiology, biomarkers & prevention
   
   A.I. Neugut et al., "ASSOCIATION BETWEEN CORONARY HEART-DISEASE AND CANCERS OF THE BREAST,PROSTATE, AND COLON", Cancer epidemiology, biomarkers & prevention, 7(10), 1998, pp. 869-873
2. KNIRSCH CA; JAIN NL; PABLOSMENDEZ A; FRIEDMAN C; HRIPCSAK G
   RESPIRATORY ISOLATION OF TUBERCULOSIS PATIENTS USING CLINICAL, GUIDELINES AND AN AUTOMATED CLINICAL DECISION-SUPPORT SYSTEM
   Infection control and hospital epidemiology
   
   C.A. Knirsch et al., "RESPIRATORY ISOLATION OF TUBERCULOSIS PATIENTS USING CLINICAL, GUIDELINES AND AN AUTOMATED CLINICAL DECISION-SUPPORT SYSTEM", Infection control and hospital epidemiology, 19(2), 1998, pp. 94-100
3. PABLOSMENDEZ A; BARR RG; SHEA S
   RUN-IN PERIODS IN RANDOMIZED TRIALS - IMPLICATIONS FOR THE APPLICATION OF RESULTS IN CLINICAL-PRACTICE
   JAMA, the journal of the American Medical Association
   
   A. Pablosmendez et al., "RUN-IN PERIODS IN RANDOMIZED TRIALS - IMPLICATIONS FOR THE APPLICATION OF RESULTS IN CLINICAL-PRACTICE", JAMA, the journal of the American Medical Association, 279(3), 1998, pp. 222-225
4. PABLOSMENDEZ A; BARR RG; SHEA S
   CONCERNS ABOUT RUN-IN PERIODS IN RANDOMIZED TRIALS - REPLY
   JAMA, the journal of the American Medical Association
   
   A. Pablosmendez et al., "CONCERNS ABOUT RUN-IN PERIODS IN RANDOMIZED TRIALS - REPLY", JAMA, the journal of the American Medical Association, 279(19), 1998, pp. 1527-1527
5. PABLOSMENDEZ A
   GLOBAL SURVEILLANCE FOR ANTITUBERCULOSIS-DRUG RESISTANCE, 1994-1997 (VOL 338, PG 1641, 1998)
   The New England journal of medicine
   
   A. Pablosmendez, "GLOBAL SURVEILLANCE FOR ANTITUBERCULOSIS-DRUG RESISTANCE, 1994-1997 (VOL 338, PG 1641, 1998)", The New England journal of medicine, 339(2), 1998, pp. 139-139
6. PABLOSMENDEZ A; RAVIGLIONE MC; NUNN P
   ANTITUBERCULOSIS-DRUG RESISTANCE - REPLY
   The New England journal of medicine
   
   A. Pablosmendez et al., "ANTITUBERCULOSIS-DRUG RESISTANCE - REPLY", The New England journal of medicine, 339(15), 1998, pp. 1080-1080
7. PABLOSMENDEZ A; RAVIGLIONE MC; LASZLO A; BINKIN N; RIEDER HL; BUSTREO F; COHN DL; LAMBREGTSVANWEEZENBEEK CSB; KIM SJ; CHAULET P; NUNN P
   GLOBAL SURVEILLANCE FOR ANTITUBERCULOSIS-DRUG RESISTANCE, 1994-1997
   The New England journal of medicine
   
   A. Pablosmendez et al., "GLOBAL SURVEILLANCE FOR ANTITUBERCULOSIS-DRUG RESISTANCE, 1994-1997", The New England journal of medicine, 338(23), 1998, pp. 1641-1649
8. PABLOSMENDEZ A; MAYEUX R; NGAI C; SHEA S; BERGLUND L
   ASSOCIATION OF APO-E POLYMORPHISM WITH PLASMA-LIPID LEVELS IN A MULTIETHNIC ELDERLY POPULATION
   Arteriosclerosis, thrombosis, and vascular biology
   
   A. Pablosmendez et al., "ASSOCIATION OF APO-E POLYMORPHISM WITH PLASMA-LIPID LEVELS IN A MULTIETHNIC ELDERLY POPULATION", Arteriosclerosis, thrombosis, and vascular biology, 17(12), 1997, pp. 3534-3541
9. DROBNIEWSKI F; PABLOSMENDEZ A; RAVIGLIONE MC
   EPIDEMIOLOGY OF TUBERCULOSIS IN THE WORLD
   Seminars in respiratory and critical care medicine
   
   F. Drobniewski et al., "EPIDEMIOLOGY OF TUBERCULOSIS IN THE WORLD", Seminars in respiratory and critical care medicine, 18(5), 1997, pp. 419-429
10. HRIPCSAK G; KNIRSCH CA; JAIN NL; PABLOSMENDEZ A
    AUTOMATED TUBERCULOSIS DETECTION
    Journal of the American Medical Informatics Association
    
    G. Hripcsak et al., "AUTOMATED TUBERCULOSIS DETECTION", Journal of the American Medical Informatics Association, 4(5), 1997, pp. 376-381
11. WALLEN M; PABLOSMENDEZ A; RADHAKRISHNAN J; APPEL G; HODGESON ME
    A PROSPECTIVE ANALYSIS OF CARDIAC MORTALITY IN PATIENTS WITH NEW-ONSET END-STAGE RENAL-DISEASE (ESRD) IN NEW-YORK-STATE
    Journal of the American Society of Nephrology
    
    M. Wallen et al., "A PROSPECTIVE ANALYSIS OF CARDIAC MORTALITY IN PATIENTS WITH NEW-ONSET END-STAGE RENAL-DISEASE (ESRD) IN NEW-YORK-STATE", Journal of the American Society of Nephrology, 8, 1997, pp. 709-709
12. PABLOSMENDEZ A; BLUSTEIN J; KNIRSCH CA
    THE ROLE OF DIABETES-MELLITUS IN THE HIGHER PREVALENCE OF TUBERCULOSIS AMONG HISPANICS
    American journal of public health
    
    A. Pablosmendez et al., "THE ROLE OF DIABETES-MELLITUS IN THE HIGHER PREVALENCE OF TUBERCULOSIS AMONG HISPANICS", American journal of public health, 87(4), 1997, pp. 574-579
13. PABLOSMENDEZ A; KNIRSCH CA; BARR RG; LERNER BH; FRIEDEN TR
    NONADHERENCE IN TUBERCULOSIS TREATMENT - PREDICTORS AND CONSEQUENCES IN NEW-YORK-CITY
    The American journal of medicine
    
    A. Pablosmendez et al., "NONADHERENCE IN TUBERCULOSIS TREATMENT - PREDICTORS AND CONSEQUENCES IN NEW-YORK-CITY", The American journal of medicine, 102(2), 1997, pp. 164-170
14. PABLOSMENDEZ A; STERLING TR; FRIEDEN TR
    THE RELATIONSHIP BETWEEN DELAYED OR INCOMPLETE TREATMENT AND ALL-CAUSE MORTALITY IN PATIENTS WITH TUBERCULOSIS
    JAMA, the journal of the American Medical Association
    
    A. Pablosmendez et al., "THE RELATIONSHIP BETWEEN DELAYED OR INCOMPLETE TREATMENT AND ALL-CAUSE MORTALITY IN PATIENTS WITH TUBERCULOSIS", JAMA, the journal of the American Medical Association, 276(15), 1996, pp. 1223-1228
15. PABLOSMENDEZ A
    MORTALITY AMONG HISPANICS
    JAMA, the journal of the American Medical Association
    
    A. Pablosmendez, "MORTALITY AMONG HISPANICS", JAMA, the journal of the American Medical Association, 271(16), 1994, pp. 1237-1238